John C. Lipscomb

3.3k total citations
69 papers, 2.6k citations indexed

About

John C. Lipscomb is a scholar working on Health, Toxicology and Mutagenesis, Pharmacology and Cancer Research. According to data from OpenAlex, John C. Lipscomb has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Health, Toxicology and Mutagenesis, 26 papers in Pharmacology and 24 papers in Cancer Research. Recurrent topics in John C. Lipscomb's work include Pharmacogenetics and Drug Metabolism (26 papers), Carcinogens and Genotoxicity Assessment (24 papers) and Effects and risks of endocrine disrupting chemicals (18 papers). John C. Lipscomb is often cited by papers focused on Pharmacogenetics and Drug Metabolism (26 papers), Carcinogens and Genotoxicity Assessment (24 papers) and Effects and risks of endocrine disrupting chemicals (18 papers). John C. Lipscomb collaborates with scholars based in United States, Canada and United Kingdom. John C. Lipscomb's co-authors include John Snawder, Hugh A. Barton, Kannan Krishnan, Torka S. Poet, Zoe Barter, Amin Rostami‐Hodjegan, Weihsueh A. Chiu, Linda K. Teuschler, Brian G. Lake and Alan R. Boobis and has published in prestigious journals such as Environmental Science & Technology, The Science of The Total Environment and Water Research.

In The Last Decade

John C. Lipscomb

67 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Lipscomb United States 26 1.1k 662 611 355 311 69 2.6k
Hugh A. Barton United States 34 1.3k 1.2× 888 1.3× 784 1.3× 515 1.5× 184 0.6× 102 3.5k
Sami Haddad Canada 35 1.2k 1.1× 536 0.8× 451 0.7× 327 0.9× 131 0.4× 117 3.0k
Jos Bessems Netherlands 23 576 0.5× 784 1.2× 216 0.4× 341 1.0× 189 0.6× 52 2.1k
Penelope A. Fenner-Crisp United States 19 1.5k 1.4× 189 0.3× 794 1.3× 668 1.9× 350 1.1× 36 2.9k
John P. Groten Netherlands 33 1.3k 1.2× 229 0.3× 419 0.7× 688 1.9× 444 1.4× 87 3.1k
M.E. Meek Canada 27 1.8k 1.6× 345 0.5× 1.1k 1.8× 580 1.6× 373 1.2× 99 3.6k
J. Odum United Kingdom 25 1.3k 1.2× 195 0.3× 574 0.9× 548 1.5× 247 0.8× 52 2.7k
Michael L. Gargas United States 37 2.1k 1.9× 856 1.3× 1.8k 2.9× 640 1.8× 417 1.3× 101 4.6k
Vicki L. Dellarco United States 28 1.3k 1.2× 311 0.5× 1.2k 2.0× 753 2.1× 218 0.7× 61 3.2k
H.B. Matthews United States 38 2.1k 1.9× 851 1.3× 1.3k 2.1× 832 2.3× 337 1.1× 138 4.5k

Countries citing papers authored by John C. Lipscomb

Since Specialization
Citations

This map shows the geographic impact of John C. Lipscomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Lipscomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Lipscomb more than expected).

Fields of papers citing papers by John C. Lipscomb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Lipscomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Lipscomb. The network helps show where John C. Lipscomb may publish in the future.

Co-authorship network of co-authors of John C. Lipscomb

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Lipscomb. A scholar is included among the top collaborators of John C. Lipscomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Lipscomb. John C. Lipscomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juberg, Daland R., Donald A. Fox, Patrick A. Forcelli, et al.. (2023). A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review. Regulatory Toxicology and Pharmacology. 143. 105444–105444. 12 indexed citations
2.
Anderson, Janet K., Ian T. Cousins, Jamie C. DeWitt, et al.. (2022). Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts. Regulatory Toxicology and Pharmacology. 134. 105226–105226. 28 indexed citations
3.
Kenyon, Elaina M., et al.. (2020). Comparison of in vivo derived and scaled in vitro metabolic rate constants for several volatile organic compounds (VOCs). Toxicology in Vitro. 69. 105002–105002. 3 indexed citations
4.
Cantwell, Mark G., David R. Katz, Julia C. Sullivan, et al.. (2017). Spatial patterns of pharmaceuticals and wastewater tracers in the Hudson River Estuary. Water Research. 137. 335–343. 109 indexed citations
5.
Bale, Ambuja S., Elaina M. Kenyon, Thomas J. Flynn, et al.. (2014). Correlating in vitro data to in vivo findings for risk assessment. ALTEX. 31(1). 79–90. 18 indexed citations
6.
Schlosser, Paul M., Gregory L. Kedderis, Mary Beth Genter, et al.. (2012). Application of an Updated Physiologically Based Pharmacokinetic Model for Chloroform to Evaluate CYP2E1-Mediated Renal Toxicity in Rats and Mice. Toxicological Sciences. 131(2). 360–374. 23 indexed citations
7.
Rice, Glenn, J. Michael Wright, E. Sidney Hunter, et al.. (2011). Identification of developmentally toxic drinking water disinfection byproducts and evaluation of data relevant to mode of action. Toxicology and Applied Pharmacology. 254(2). 100–126. 44 indexed citations
8.
Wang, Tao, David Jacobson‐Kram, Anne M. Pilaro, et al.. (2010). ICH Guidelines: Inception, Revision, and Implications for Drug Development. Toxicological Sciences. 118(2). 356–367. 10 indexed citations
9.
Mazur, Christopher S., John F. Kenneke, Janet K. Hess-Wilson, & John C. Lipscomb. (2010). Differences between Human and Rat Intestinal and Hepatic Bisphenol A Glucuronidation and the Influence of Alamethicin on In Vitro Kinetic Measurements. Drug Metabolism and Disposition. 38(12). 2232–2238. 50 indexed citations
10.
Mahle, Deirdre A., Jeffery M. Gearhart, Claude C. Grigsby, et al.. (2007). Age-Dependent Partition Coefficients for a Mixture of Volatile Organic Solvents in Sprague-Dawley Rats and Humans. Journal of Toxicology and Environmental Health. 70(20). 1745–1751. 18 indexed citations
11.
Chiu, Weihsueh A., Miles S. Okino, John C. Lipscomb, & Marina V. Evans. (2006). Issues in the Pharmacokinetics of Trichloroethylene and Its Metabolites. Environmental Health Perspectives. 114(9). 1450–1456. 27 indexed citations
12.
Lipscomb, John C., David R. Mattie, & Darol E. Dodd. (2005). Introduction. Journal of Toxicology and Environmental Health. 68(11-12). 833–836. 1 indexed citations
13.
Lipscomb, John C., et al.. (2003). Variance of Microsomal Protein and Cytochrome P450 2E1 and 3A Forms in Adult Human Liver. Toxicology Mechanisms and Methods. 13(1). 45–51. 44 indexed citations
14.
Donohue, Joyce M. & John C. Lipscomb. (2002). Health advisory values for drinking water contaminants and the methodology for determining acute exposure values. The Science of The Total Environment. 288(1-2). 43–49. 5 indexed citations
15.
Byczkowski, Janusz Z. & John C. Lipscomb. (2001). Physiologically Based Pharmacokinetic Modeling of the Lactational Transfer of Methylmercury. Risk Analysis. 21(5). 869–869. 19 indexed citations
16.
Moudgal, Chandrika, John C. Lipscomb, & Robert M. Bruce. (2000). Potential health effects of drinking water disinfection by-products using quantitative structure toxicity relationship. Toxicology. 147(2). 109–131. 54 indexed citations
17.
Lipscomb, John C., et al.. (1997). Cytochrome P450-Dependent Metabolism of Trichloroethylene: Interindividual Differences in Humans. Toxicology and Applied Pharmacology. 142(2). 311–318. 63 indexed citations
18.
Barton, Hugh A., Carlyle D. Flemming, & John C. Lipscomb. (1996). Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology. 111(1-3). 271–287. 12 indexed citations
19.
Witzmann, Frank A., et al.. (1996). Toxicant‐induced alterations in two‐dimensional electrophoretic patterns of hepatic and renal stress proteins. Electrophoresis. 17(1). 198–202. 18 indexed citations
20.
Witzmann, Frank A., et al.. (1996). Effect of structurally diverse peroxisome proliferators on rat hepatic sulfotransferase. Chemico-Biological Interactions. 99(1-3). 73–84. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh A. Barton Breakdown of academic impact, for papers by Sami Haddad Breakdown of academic impact, for papers by Jos Bessems Breakdown of academic impact, for papers by Penelope A. Fenner-Crisp Breakdown of academic impact, for papers by John P. Groten Breakdown of academic impact, for papers by M.E. Meek Breakdown of academic impact, for papers by J. Odum Breakdown of academic impact, for papers by Michael L. Gargas Breakdown of academic impact, for papers by Vicki L. Dellarco Breakdown of academic impact, for papers by H.B. Matthews
Rankless by CCL
2026